Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.20.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2019
Dec. 31, 2018
Current assets:    
Cash and cash equivalents $ 1,338 $ 896
Trade receivables 111 95
Other accounts receivable and prepaid expenses 268 95
Inventory 121 144
Total current assets 1,838 1,230
Non-current assets:    
Fixed assets, net 4 8
Severance pay fund 194 342
Total non-current assets 198 350
Total assets 2,036 1,580
Current liabilities:    
Trade payables 129 193
Other accounts payable and accrued expenses 280 447
Total current liabilities 409 640
Non-current liabilities:    
Accrued severance pay 279 477
Total liabilities 688 1,117
COMMITMENTS AND CONTINGENCIES (Note 11)
Stockholders' equity:    
Common stock of $0.001 par value - Authorized: 24,000,000 shares at December 31, 2019 and 2018; Issued and outstanding: 4,203,764 and 3,801,522 shares at December 31, 2019 and 2018, respectively 5 4
Additional paid in capital 39,669 32,993
Accumulated deficit (38,330) (32,536)
Total stockholders' equity 1,348 463
Total liabilities and stockholders' equity 2,036 1,580
Series C Preferred Stock [Member]    
Stockholders' equity:    
Preferred stock value 2 2
Total stockholders' equity 2 2
Series D Preferred Stock [Member]    
Stockholders' equity:    
Preferred stock value
Total stockholders' equity
Series E Preferred Stock [Member]    
Stockholders' equity:    
Preferred stock value 2
Total stockholders' equity $ 2